Detalles de la búsqueda
1.
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.
Br J Haematol
; 193(2): 325-338, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33605445
2.
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 385(9980): 1853-62, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25796459
3.
A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.
Leuk Lymphoma
; 59(12): 2888-2895, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846137
4.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial.
Lancet Haematol
; 4(8): e362-e373, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28712940
Resultados
1 -
4
de 4
1
Próxima >
>>